Valion Bio VBIO Income Statement (2021-2026)

NASDAQ VBIO
$0.12 -0.01 (-7.69%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Revenue & cost
Revenue (Quarter)
0.27M0.28M0.39M0.43M0.53M0.48M0.41M0.38M0.16M0.28M0.36M0.33M0.14M0.13M0.18M0.07M0.09M0.15M0.08M0.04M
Cost of Revenue (Quarter)
0.30M0.30M0.39M0.36M0.40M0.41M0.36M0.26M0.10M0.17M0.35M0.17M0.11M0.08M0.42M0.02M0.03M0.29M0.01M0.01M
Gross Profit (Quarter)
-0.03M-0.03M-0.00M0.07M0.12M0.06M0.04M0.11M0.06M0.11M0.01M0.17M0.03M0.04M-0.24M0.05M0.05M-0.14M0.07M-0.04M
Operating items
Research & Development (Quarter)
0.34M0.17M1.22M0.40M0.50M0.49M0.43M0.49M0.45M0.34M0.36M0.51M0.30M0.23M0.21M0.18M0.43M0.86M
Selling, General & Administrative (Quarter)
0.48M0.58M1.28M1.23M1.52M1.76M1.36M1.28M1.27M1.05M1.15M0.89M0.79M0.82M0.67M1.04M0.91M1.06M
Other Operating Expenses (Quarter)
0.19M0.45M-0.22M0.68M1.12M0.40M0.50M0.46M0.47M0.48M0.73M0.26M0.21M0.37M0.34M0.66M-0.12M
Operating Expenses (Quarter)
1.02M1.20M2.29M2.31M3.14M2.65M2.30M2.23M2.19M1.87M2.25M1.65M1.30M1.48M1.24M1.56M1.99M2.34M
Operating Income (Quarter)
-1.05M-1.23M-2.29M-2.24M-3.02M-2.58M-2.26M-2.12M-2.12M-1.76M-2.24M-1.48M-1.27M-1.43M-1.48M-1.51M-1.93M-2.48M0.07M-0.04M
EBIT (Quarter)
-1.05M-1.23M-2.29M-2.24M-3.02M-2.58M-2.26M-2.12M-2.12M-1.76M-2.24M-1.48M-1.27M-1.43M-1.48M-1.51M-1.93M-2.48M0.07M-0.04M
Non-operating items
Interest & Investment Income (Quarter)
0.00M
Other Non Operating Income (Quarter)
0.16M0.08M-1.72M-0.00M
Non Operating Income (Quarter)
-0.04M-1.09M-1.43M0.00M0.00M-0.06M0.01M0.00M0.00M-0.11M
Net income details
EBT (Quarter)
-1.28M-1.23M-2.29M-2.56M-3.07M-2.63M-2.31M-2.17M-2.18M-1.81M-2.30M-1.53M-1.33M-1.43M-1.51M-1.51M-1.93M-2.48M0.07M-15.62M
Profit After Tax (Quarter)
-1.09M-2.32M-3.72M-2.24M-3.02M-2.58M-2.25M-2.12M-2.12M-1.76M-2.24M-1.48M-1.27M-1.43M-1.46M-1.50M-1.93M-2.60M0.07M-15.62M
Income from Continuing Operations (Quarter)
-1.28M-1.23M-2.29M-2.56M-3.07M-2.63M-2.31M-2.17M-2.18M-1.81M-2.30M-1.53M-1.33M-1.43M-1.51M-1.51M-1.93M-2.48M0.07M-15.62M
Consolidated Net Income (Quarter)
-1.28M-1.23M-2.29M-2.56M-3.07M-2.63M-2.31M-2.17M-2.18M-1.81M-2.30M-1.53M-1.33M-1.43M-1.51M-1.51M-1.93M-2.48M0.07M-15.62M
Income towards Parent Company (Quarter)
-1.28M-1.23M-2.29M-2.56M-3.07M-2.63M-2.31M-2.17M-2.18M-1.81M-2.30M-1.53M-1.33M-1.43M-1.51M-1.51M-1.93M-2.48M0.07M-15.62M
Net Income towards Common Stockholders (Quarter)
-1.28M-1.23M-2.29M-2.24M-3.07M-2.63M-2.31M-2.17M-2.18M-1.81M-2.30M-1.53M-1.33M-1.43M-1.51M-1.51M-1.93M-2.48M0.07M-15.62M
Additional items
EPS (Basic) (Quarter)
-0.54-0.48-0.66-0.23-0.32-0.27-0.24-0.11-0.07-1.52-2.90-1.04-0.33-0.23-5.25-2.53-2.19-1.880.06-4.62
EPS (Diluted) (Quarter)
-0.54-0.48-0.66-0.23-0.32-0.27-0.24-0.11-0.07-1.52-2.90-1.04-0.33-0.23-5.25-2.53-2.19-2.810.08-17.72
Shares Outstanding (Quarter)
2.37M2.58M3.49M9.72M9.62M9.68M9.67M20.12M29.68M1.19M0.79M1.47M4.01M6.19M0.29M0.60M0.88M1.32M1.16M3.38M
Shares Outstanding (Diluted) (Quarter)
2.37M2.58M3.49M9.72M9.62M9.68M9.67M20.12M29.68M1.19M0.79M1.47M4.01M6.19M0.29M0.60M0.88M0.88M0.88M0.88M
Shares Outstanding (Entity) (Quarter)
2.37M2.58M3.49M9.72M9.62M9.68M9.68M20.12M29.68M1.19M0.79M1.47M4.01M6.24M0.29M0.71M0.97M1.32M1.16M3.38M
EBITDA (Quarter)
-1.05M-1.23M-2.29M-2.24M-3.02M-2.58M-2.26M-2.12M-2.12M-1.76M-2.24M-1.48M-1.27M-1.43M-1.48M-1.51M-1.93M-2.48M0.07M-0.04M
Interest Expenses (Quarter)
0.22M0.32M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.06M0.03M0.17M15.57M